Alan Meds advertises two conflicting cash-pay structures for compounded semaglutide: a buy-one-get-one promotional rate and a first-month/refill model. We normalize both against transparent baselines and show the 12-month cost.

AltRx charges no separate membership fee; all costs—medication, provider visit, support, and shipping—are bundled into a single monthly or prepaid medication price starting at $89/month for semaglutide under a promotional offer captured September 2026.

AltRx advertised compounded semaglutide at promotional rates through September 5, 2026, but post-promotion pricing remains undocumented. We compare what is known, flag the gaps, and show transparent long-term costs elsewhere.

AltRx advertises compounded semaglutide from $89/month and tirzepatide from $149/month through September 5, 2026. The promotion includes all services at one price—but the standard refill rate after the sale ends is not disclosed, making total cost uncertain.

AltRx's promotional rates expire September 5, 2026; post-promotional pricing is undocumented. We compare advertised costs, billing-practice reports, and service stability for readers considering a switch.

AltRx offers compounded semaglutide and tirzepatide injections at promotional rates valid through September 5, 2026, with no separate membership fees. We review the pricing structure, cancellation terms, and service reliability reports to help you decide if the program fits your situation.

AltRx is running a promotional tirzepatide campaign through September 5, 2026, with rates from $149 per month on a month-to-month basis down to $125 per month prepaid annually. We compare the promotional structure against standard plans and examine what happens when the promotion ends.